Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:24 pm Sale | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 11,597,737 8.100% | -1,924,102 (-14.23%) | Filing History |
| 2026-05-15 4:23 pm Purchase | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | Nextech Crossover I GP S.a. r.l. | 7,266,081 5.100% | 1,732,101 (+31.30%) | Filing History |
| 2026-05-15 09:16 am Sale | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | Woodline Partners LP | 8,000,013 5.600% | -2,072,212 (-20.57%) | Filing History |
| 2026-05-15 08:34 am Purchase | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | RTW Investments, LP | 13,300,620 9.300% | 13,300,620 (New Position) | Filing History |
| 2026-05-13 09:18 am Purchase | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | Adage Capital Management, L.P. | 12,809,485 8.980% | 2,201,561 (+20.75%) | Filing History |
| 2026-05-11 08:49 am Purchase | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | Farallon Capital Partners, L.P. | 11,257,203 7.800% | 500,203 (+4.65%) | Filing History |
| 2026-05-06 11:40 am Purchase | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | FMR LLC | 9,905,919 6.900% | 9,892,527 (+73868.93%) | Filing History |
| 2026-05-04 2:39 pm Sale | 2026-03-31 | 13G | TANGO THERAPEUTICS INC TNGX | Invus Public Equities, L.P. | 5,657,105 4.000% | -2,508,269 (-30.72%) | Filing History |
| 2026-03-27 1:31 pm Sale | 2026-03-13 | 13G | TANGO THERAPEUTICS INC TNGX | VANGUARD GROUP INC | 0 0.000% | -6,750,977 (Position Closed) | Filing History |
| 2026-02-17 6:29 pm Sale | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | EcoR1 Capital, LLC | 0 0.000% | -10,630,736 (Position Closed) | Filing History |
| 2026-02-17 4:22 pm Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 13,521,839 9.990% | 4,985,643 (+58.41%) | Filing History |
| 2026-02-17 3:22 pm Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | Woodline Partners LP | 10,072,225 7.500% | 4,042,319 (+67.04%) | Filing History |
| 2026-02-13 11:47 am Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | Invus Public Equities, L.P. | 8,165,374 6.100% | 2,282,186 (+38.79%) | Filing History |
| 2026-02-12 09:11 am Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | Adage Capital Management, L.P. | 10,607,924 7.880% | 8,096,924 (+322.46%) | Filing History |
| 2026-02-10 4:15 pm Sale | 2026-02-06 | 13D | TANGO THERAPEUTICS INC TNGX | Third Rock Ventures IV, L.P. | 6,374,574 4.740% | -1,500,000 (-19.05%) | Filing History |
| 2026-02-06 4:11 pm Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | Farallon Capital Partners, L.P. | 13,461,215 9.990% | 13,461,215 (New Position) | Filing History |
| 2026-01-30 2:44 pm Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | VANGUARD GROUP INC | 6,750,977 5.010% | 6,750,977 (New Position) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | TANGO THERAPEUTICS INC TNGX | BlackRock, Inc. BLK | 8,477,165 6.300% | 3,020,135 (+55.34%) | Filing History |
| 2025-11-21 4:15 pm Sale | 2025-11-19 | 13D | TANGO THERAPEUTICS INC TNGX | Third Rock Ventures IV, L.P. | 7,874,574 5.850% | -1,500,000 (-16.00%) | Filing History |
| 2025-11-14 4:23 pm Sale | 2025-09-30 | 13G | TANGO THERAPEUTICS INC TNGX | TCG Crossover GP II, LLC | 8,536,196 6.300% | -1,964,416 (-18.71%) | Filing History |